1,871 results on '"Bourhis J."'
Search Results
2. Proposition de délinéation des volumes cibles anatomocliniques postopératoires de la tumeur primitive des cancers du sinus maxillaire et des cavités nasales
3. Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
4. A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients
5. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
6. Proposition de délinéation des volumes cibles anatomocliniques postopératoires de la tumeur primitive des cancers de l’ethmoïde
7. Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 cases
8. Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers
9. Exploration of clinical preferences in treatment planning of radiotherapy for prostate cancer using Pareto fronts and clinical grading analysis
10. Mid-term outcomes after stereotactic arrhythmia radioablation for refractory ventricular tachycardia
11. Mission ESTRO 2019 : focus physique en radiothérapie
12. Protonthérapie des carcinomes épidermoïdes des voies aérodigestives supérieures : de la physique à la clinique
13. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
14. Chimioradiothérapie des cancers de l’œsophage : revue critique de la littérature
15. (18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy
16. A randomized trial of induction docetaxel–cisplatin–5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02)
17. PET-based prognostic survival model after radiotherapy for head and neck cancer
18. ESTRO 2017 : état de l’art en radiothérapie
19. Doses aux organes à risque en radiothérapie conformationnelle et en radiothérapie stéréotaxique : les poumons
20. Présentation de l’étude Gortec 2017-03 : radiothérapie en conditions stéréotaxiques postopératoire des cancers localisés de l’oropharynx et de la cavité buccale avec marges à risque (PHRC-K-16-164)
21. A PET-based nomogram for oropharyngeal cancers
22. Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017–03 phase 2 trial
23. Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy
24. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
25. Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the swiss cohort
26. Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the Swiss cohort
27. MO-0717 Seasonality of radiotherapy efficacy for head & neck cancer patients: MACH-NC/MARCH meta-analyses
28. Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
29. Méta-analyses d’essais randomisés sur données individuelles dans le traitement des cancers ORL non métastatiques : principes, résultats, perspectives
30. Total body irradiation/fludarabine versus busulfan/fludarabine as conditioning in all patients > 45 years in 1sr CR - a registry-based study by the ALWP of the EBMT [Abstract]
31. Résultats de la radiothérapie dans les carcinomes épidermoïdes du larynx avec atteinte sous-glottique
32. Allogeneic stem cell transplantation for acute myeloid leukemia with normal cytogenetics (CN-AML): outcome, risk factors and role of molecular subgroups in 1006 patients - a report from the Acute Leukemia Working Party of EBMT [Abstract]
33. Factors determining the kinetics of disease relapse after allogeneic stem cell transplantation (allo-SCT) for acute myeloid leukaemia (AML): a survey from the Acute Leukaemia Working Party of the EBMT [Abstract]
34. Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin’s lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
35. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party
36. Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
37. Refractory ventricular tachycardia treated by a second session of stereotactic arrhythmia radioablation
38. Recurrences after stereotactic arrhythmia radioablation for refractory ventricular tachycardia
39. 706TiP Phase III study assessing the “best of” radiotherapy compared to the “best of” surgery (trans-oral surgery (TOS)) in patients with T1-T2, N0-N1 oropharyngeal, supraglottic carcinoma and with T1, N0 hypopharyngeal carcinoma
40. LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study
41. 675P Patterns of radiological responses to anti-PD1 in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
42. Évolution des concepts dans les cancers des voies aérodigestives supérieures, sous l’égide de l’Intergroupe ORL (GORTEC, GETTEC, GERCOR)
43. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma
44. Curiethérapie des cancers des voies aérodigestives supérieures
45. Modified Fractionated Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC) & Re-Irradiation in Recurrent Head and Neck Carcinomas
46. 895P Cost effectiveness of stereotactic ablative radiotherapy (SABR) alone in comparison with systemic treatment and SABR in oligometastatic head and neck cancer in the GORTEC 2014-04 OMET randomized phase II study
47. 869P Results of the multicenter phase II FRAIL-IMMUNE trial evaluating the efficacy and safety of durvalumab (D) combined with weekly paclitaxel carboplatin in 1st-line in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) not eligible to cisplatin
48. 854MO Avelumab-cetuximab-radiotherapy (RT) versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Final analysis of randomized phase III GORTEC 2017-01 REACH trial
49. 852MO REWRITE–GORTEC 2018-02: Radiotherapy-durvalumab without prophylactic neck irradiation in squamous cell carcinoma of the head and neck
50. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.